跳至主要内容
临床试验/NCT02950116
NCT02950116终止不适用

Lung Clearance Index in Pediatric Patients With Obstructive Lung Disease

Universitair Ziekenhuis Brussel2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2017年3月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
27
试验地点
2
主要终点
LCI

研究概览

简要总结

Chronic respiratory diseases (CRDs) affect the airways and other structures of the lungs and thereby lead to ventilation inhomogeneity. The most common CRDs in children are asthma, bronchiectasis and cystic fibrosis (CF). All three are obstructive diseases. However, while asthma is mostly characterized by obstruction due to bronchoconstriction of the airways, obstruction in bronchiectasis and CF originates primarily from mucus retention due to abnormal airway clearance mechanisms.

The Nitrogen Multiple Breath Washout test (N2-MBW-test) is a robust and sensitive detector of early pulmonary changes and ventilation inhomogeneity. The minimal cooperation which is required for this test makes it very convenient for use in any age category.

Research on LCI described it as a reliable indicator of obstructive lung disease in pediatric CF patients as from 6 years of age. Whether LCI is a reliable parameter for early lung disease in asthma children is less clearly demonstrated. No data were found on LCI calculated from the N2-MBW-test in children with bronchiectasis.

详细描述

Subjects of all the intervention groups will perform three consecutive nitrogen multiple breath washout tests (N2-MBW-tests) when attending the Universitair Ziekenhuis Brussel (UZB) for their scheduled pulmonology consultation. Only the best measurement (based on LCI result) will be taken into account when comparing the groups. Every subject will be positioned in the same seated position.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients with stable asthma
  • Patients with non-CF bronchiectasis
  • Patients with cystic fibrosis
  • Aged 6-17 years
  • FEV1 (%pred) >50%
  • Written informed consent from the parents or legal guardian

排除标准

  • Unstable disease (e.g. pulmonary exacerbation, acute deterioration, acute asthma crisis)
  • Patients mentally not capable to participate in the study

结局指标

主要结局

LCI

时间窗: Day 1

LCI will be calculated from the 3 N2-MBW-tests. The test with the lowest LCI will be used for analysis of the other outcome measurements.

次要结局

  • S_acin(Day 1)
  • Number of washout breaths(Day 1)
  • FRC(Day 1)
  • Duration of the N2-MBW-test(Day 1)
  • S_cond(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验